Developer of protein therapeutics designed to prevent and treat lethal Gram-negative bacterial infections. The company's protein therapeutics offers a panel of human therapeutic protein candidates and novel pipelines of anti-bacterial drugs capable of combating serious bacterial infections and of withstanding the cunning efforts of bacteria to develop drug-resistant mechanisms, enabling doctors to treat and prevent lethal Gram-negative bacterial infections associated primarily within the hospital setting.